2021-01-07,RedHill's (RDHL) RHB-204 Gets FDA Fast Track Designation
2020-12-16,"The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal"
2020-12-16,BioLineRx Announces Final Results from Phase 2a COMBAT/KEYNOTE-202 Triple Combination Study of Motixafortide in Second Line Metastatic Pancreatic Cancer (PDAC)
2020-12-02,Here is What Hedge Funds Think About Bioline RX Ltd (BLRX)
2020-12-01,Fusion Pharmaceuticals (FUSN) Jumps: Stock Rises 9%
2020-11-23,BioLineRx Ltd. to Host Earnings Call
2020-11-23,BioLineRx Reports Third Quarter 2020 Financial Results and Provides Corporate Update
2020-11-19,Pacira (PCRX) Gets European Commission Approval for Exparel
2020-11-18,"BioLineRx to Report Third Quarter 2020 Results on November 23, 2020"
2020-11-18,BioLineRx Announces Initiation of Phase 1b Clinical Trial in Patients with Acute Respiratory Distress Syndrome (ARDS) Secondary to COVID-19 and Other Respiratory Viral Infections
2020-11-16,Aerie (AERI) Gets Positive CHMP Opinion for Roclanda in EU
2020-11-13,Zoetis (ZTS) Librela Gets Marketing Authorization in Europe
2020-11-11,Merck's (MRK) Keytruda Combo Meets Goal in Kidney Cancer Study
2020-11-10,ChemoCentryx (CCXI) Reports Wider-Than-Expected Q3 Loss
2020-11-10,"Catalyst's (CPRX) Q3 Earnings Beat Estimates, Revenues Miss"
2020-11-06,"Sarepta (SRPT) Q3 Loss Widens Y/Y, Revenues Beat Estimates"
2020-11-06,"Aerie (AERI) Q3 Loss Narrower Than Expected, Sales Rise Y/Y"
2020-11-06,"Amarin's (AMRN) Q3 Earnings Lag, Sales In Line, Stock Down"
2020-11-05,"Perrigo (PRGO) Q3 Earnings Beat, Revenues Miss, Stock Up"
2020-11-01,BioLineRx Pops 34% On Positive Results From Cancer Stem Cell Trial
2020-10-30,BioLine stock soars on heavy volume after 'compelling' results of cancer treatment trial
2020-10-30,BioLineRx Announces Positive Results from Interim Analysis of GENESIS Phase 3 Trial of Motixafortide (BL-8040) in Stem Cell Mobilization
2020-10-29,BioLineRx Announces Initiation of Phase 2 Clinical Trial in First-Line Metastatic Pancreatic Cancer
2020-09-09,Radius Completes Enrollment in Phase III Osteoporosis Study
2020-08-19,BioLineRx Achieves Enrollment Target in Phase 3 GENESIS Trial for Planned Interim Analysis
2020-08-06,BioLineRx Reports Second Quarter 2020 Financial Results and Provides Corporate Update
2020-07-31,"BioLineRx to Report Second Quarter 2020 Results on August 6, 2020"
2020-07-24,BioLineRx (BLRX) to Report Q2 Earnings: What's in the Cards?
2020-07-08,Aclaris (ACRS) Surges: Stock Moves 5.4% Higher
2020-07-06,Acceleron (XLRN) in Focus: Stock Moves 5.3% Higher
2020-07-02,Zogenix (ZGNX) in Focus: Stock Moves 7.6% Higher
2020-06-30,CytoDyn Signs MOU With NIH of Mexico for Coronavirus Study
2020-06-16,Jazz's Aggressive Lung Cancer Drug Zepzelca Gets FDA Approval
2020-06-04,Is Bioline RX Ltd (BLRX) Going to Burn These Hedge Funds?
2020-06-01,BioLineRx Announces $4.39 Million Registered Direct Offering
2020-05-29,Top Ranked Momentum Stocks to Buy for May 29th
2020-05-27,3 Strong Buy Biotech Stocks Under $5 With Explosive Upside Potential
2020-05-27,BioLineRx Announces Publication of Data from Ongoing COMBAT/KEYNOTE-202 Clinical Trial in Nature Medicine
2020-05-26,BioLineRx Announces $9.0 Million Registered Direct Offering
2020-05-20,BioLineRx Ltd. to Host Earnings Call
2020-05-20,BioLineRx Reports First Quarter 2020 Financial Results and Provides Corporate Update
2020-05-15,"BioLineRx to Report First Quarter 2020 Results on May 20, 2020"
2020-03-12,BioLineRx Ltd. to Host Earnings Call
2020-03-12,BioLineRx Reports Year-End 2019 Financial Results and Provides Corporate Update
2020-03-06,"BioLineRx to Report Annual 2019 Results on March 12, 2020"
2020-02-27,BioLineRx Announces Notice of Allowance from USPTO for Patent Covering Motixafortide (BL-8040) in Combination With Anti-PD-1 for the Treatment of Any Type of Cancer
2020-01-23,BioLineRx Concludes Recruitment in Pancreatic Cancer Study
2020-01-22,BioLineRx Completes Recruitment in Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Patients With Second-line Metastatic Pancreatic Cancer
2020-01-15,BioLineRx's Pancreatic Cancer Drug Gets Orphan Drug Tag in EU
2020-01-14,BioLineRx Receives Orphan Drug Designation for Motixafortide (BL-8040) for the Treatment of Pancreatic Cancer in Europe
2020-01-08,BioLineRx to Present at the 2020 Biotech Showcase
2019-12-13,BioLineRx Announces Updated Phase 2a Data From Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Patients With Second-line Metastatic Pancreatic Cancer
2019-12-06,"The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend"
2019-12-05,BioLineRx Announces Preliminary Phase 2a Data from Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Second Line Patients With Metastatic Pancreatic Cancer
2019-11-26,"BioLineRx to Host Investor and Analyst Breakfast Meeting on December 5, 2019 in New York"
2019-11-11,BioLineRx Reports Third Quarter 2019 Financial Results and Provides Corporate Update
2019-11-06,"BioLineRx to Report Third Quarter 2019 Results on November 11, 2019"
2019-11-05,BioLineRx Announces BL-8040 in Combination With KEYTRUDA Shows Clinical Activity in Heavily Pretreated Metastatic Pancreatic Cancer Patients
2019-11-05,"BioLineRx Presents Preclinical Data From Triple Combination of BL-8040, Anti PD-1 and Chemotherapy Demonstrating Significant Reduction in Pancreatic Tumor Growth and Favorable Changes in Tumor Microenvironment"
2019-10-31,BioLineRx to Present Two Posters at the Society for Immunotherapy of Cancer (SITC) 2019
2019-10-29,BioLineRx to Deliver Oral Presentation at ESMO Immuno-Oncology Congress 2019
2019-09-26,BioLineRx Begins Part 2 of Phase I/IIa Study on Solid Tumors
2019-09-25,"BioLineRx Announces Dosing of First Patient in Part 2 of Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors"
2019-09-04,"The Daily Biotech Pulse: Puma Leaps, Aerie Borrows, Hepion Back In Nasdaq's Good Books"
2019-09-03,"BioLineRx Successfully Completes Dose-Escalation Part of Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors"
2019-08-06,BioLineRx Reports Second Quarter 2019 Financial Results and Provides Corporate Update
2019-08-02,Tenet Healthcare (THC) Q2 Earnings: What's in the Cards?
2019-07-30,"BioLineRx to Report Second Quarter 2019 Results on August 6, 2019"
2019-06-28,BioLineRx Announces Change in Ratio of American Depositary Shares to Ordinary Shares
2019-06-13,BioLineRx to Present at the JMP Securities 2019 Life Sciences Conference
2019-05-17,BioLineRx (BLRX) Moves to Buy: Rationale Behind the Upgrade
2019-05-14,BioLineRx Reports First Quarter 2019 Financial Results and Provides Corporate Update
2019-05-07,"BioLineRx to Report First Quarter 2019 Results on May 14, 2019"
2019-05-07,"BioLineRx Announces FDA Approval of IND Application for AGI-134, a Novel Immunotherapy Anti-Cancer Vaccine for Solid Tumors"
2019-05-01,"Biotech News, What Milestones and Catalysts Could Drive BioLineRx Shares in 2019"
2019-03-28,BioLineRx Reports Year End 2018 Financial Results and Provides Corporate Update
2019-03-27,Four Tech Stocks Sparking Activity on Wednesday
2019-03-27,BioLineRx Announces Successful Engraftment Data From Phase 3 GENESIS Trial for BL-8040 in Multiple Myeloma Patients
2019-03-21,"BioLineRx to Report Annual 2018 Results on March 28, 2019"
2019-03-14,BioLineRx to Present at the 29th Annual Oppenheimer Healthcare Conference
2019-02-07,BioLineRx Announces Closing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
2019-02-07,BioLineRx Announces Closing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
2019-02-05,BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
2019-02-05,Biotech on the Brink of Breaking Out
2019-02-05,BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
2019-02-05,"The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results"
2019-02-04,BioLineRx Announces Proposed Underwritten Public Offering of its American Depositary Shares and Warrants
2019-02-04,Watch These 4 Healthcare Stocks Set The Pace On Monday (2/4/19)
2019-02-04,BioLineRx Receives Orphan Drug Designation From the FDA for its Lead Therapeutic Candidate BL-8040 for the Treatment of Pancreatic Cancer
2019-01-02,BioLineRx to Present at the 2019 Biotech Showcase
2018-12-11,BioLineRx Announces Initiation of Triple Combination Arm of Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer Under Immuno-Oncology Collaboration
2018-12-06,"BioLineRx to Host Investor and Analyst Breakfast Meeting on December 11, 2018 in New York"
2018-11-20,New Healthcare Trends Have Investors Looking at 4 Stocks
2018-11-20,BioLineRx Announces Receipt of FDA Biological Product Designation for Novel Cancer Immunotherapy Candidate AGI-134
2018-11-16,"Recent Analysis Shows BioLineRx, Interlink Electronics, IMV INC, PAR Technology, Hudson Global, and Identiv Market Influences  Renewed Outlook, Key Drivers of Growth"
2018-11-08,BioLineRx Reports Significant Progress Across Oncology Programs and Provides Third Quarter Financial Update
2018-11-01,"BioLineRx to Report Third Quarter 2018 Results on November 8, 2018"
2018-10-20,BioLineRx Discloses Additional Data from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress
2018-10-19,BioLineRx Presents Top-line Results from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress
2018-10-17,"BioLineRx, High Potential Near Term Catalysts, Analysts Review and Target"
